European Union - English - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Ireland - English - HPRA (Health Products Regulatory Authority)

pharma nord aps - melatonin - film-coated tablet - 3 milligram(s) - melatonin

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharma nord aps - melatonin 3 mg - film-coated tablet - 3 mg - melatonin 3 mg - melatonin

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl), nadide (unii: 0u46u6e8uk) (nadide - unii:0u46u6e8uk), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), sus scrofa pituitary gland (unii: l0pfemq1dt) (sus scrofa pituitary gland - unii:l0pfemq1dt), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), l - melatonin 6 [hp_x] in 1 ml - for temporary relief of imbalances in menstruation and ovulation, insomnia, dysmenorrhea and imbalance in menstrual cycle. for temporary relief of imbalances in menstruation and ovulation, insomnia, dysmenorrhea and imbalance in menstrual cycle.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - melatonin 6 [hp_x] in 1 ml - for temporary relief of fatigue, irritability, insomnia, and exhaustion. for temporary relief of fatigue, irritability, insomnia, and exhaustion.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - melatonin 6 [hp_x] in 1 ml - for temporary relief of symptoms related to sleep issues and jet lag.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to sleep issues and jet lag.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

apotheca company - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - melatonin 200 [hp_c] in 1 ml - indications:   for temporary relief of symptoms related to sleep disorders, seasonal affective disorder, jet lag, and depression. indications:   for temporary relief of symptoms related to sleep disorders, seasonal affective disorder, jet lag, and depression.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - melatonin 2 mg - prolonged-release tablet - 2 mg - melatonin 2 mg - melatonin

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; purified talc; colloidal anhydrous silica; ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.